Sanda Pharmaprojects Private Limited

Sanda Pharmaprojects Private Limited - business outsourcing in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH2019PTC328946 Incorporated 06 August 2019 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company business outsourcing
Data last updated
Revenue · FY 2024
₹1.49 Cr
▲ 70% YoY
Net profit · FY 2024
₹13.29 Lakh
Net margin 8.9%
EBITDA · FY 2024
₹24.72 Lakh
EBITDA margin 16.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹50,000
Issued & subscribed
Open charges
₹37.21 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings

About Sanda Pharmaprojects Private Limited

Data last updated:

Sanda Pharmaprojects Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 06 August 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2019PTC328946. Its GSTIN is 27ABCCS4583N1ZP (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹50,000. It is led by directors Sandeep Vilasrao Patil and Sheetal Virendrasingh Girase.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. B – 7/1 Kothari Compound 27 Acres Chitalsar Manpada Thane West, Maharashtra, India – 400607.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.49 Cr, a growth of 70% compared to the previous year. For the same year it recorded a net profit of ₹13.29 Lakh (net margin 8.9%) and EBITDA of ₹24.72 Lakh (EBITDA margin 16.6%). Revenue has grown at a compounded annual rate (CAGR) of 77% over three years.

As per MCA filings, the company has open charges of ₹37.21 Lakh on record.

For more details, the company can be reached via its website snapharmaprojects.com.

Company Details of Sanda Pharmaprojects Private Limited
CIN U24239MH2019PTC328946
Registration Number 328946
Incorporation Date 06 August 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Plot No. B – 7/1 Kothari Compound 27 Acres Chitalsar Manpada Thane West, Maharashtra, India – 400607
  • Industry
    Business Outsourcing, Business & IT Consulting
Comprehensive company report
Sanda Pharmaprojects Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Sanda Pharmaprojects Private Limited report

Financials, compliance, directors, charges, ownership and filings for Sanda Pharmaprojects Private Limited in one report.

Financials from FY 2020 Directors & ownership Charges & compliance

Business Activity of Sanda Pharmaprojects Private Limited

The main business activity of Sanda Pharmaprojects is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Sanda Pharmaprojects Private Limited FY 2025 filings available

Sanda Pharmaprojects Private Limited reported revenue of ₹1.49 Cr (up 70% YoY) for FY 2024.

Revenue · FY 2024
₹1.49 Cr ▲ 70%
Net profit · FY 2024
₹13.29 Lakh margin 8.9%
EBITDA · FY 2024
₹24.72 Lakh margin 16.6%

Compounded Annual Growth Rate (CAGR) of Sanda Pharmaprojects Private Limited

Revenue CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 77%
EBITDA CAGR growth
1 year
▲ 49%
3 years · compounded
▲ 103%

Revenue has grown at a compounded annual rate (CAGR) of 77% over three years, including 70% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Sanda Pharmaprojects Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹24.72 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹13.29 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Sanda Pharmaprojects Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin16.6%••••••••••••••••
Net Profit Margin8.9%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sanda Pharmaprojects are in the company report.

Premium access

Financial statements from FY 2020

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Sanda Pharmaprojects Private Limited

Sanda Pharmaprojects Private Limited is compared with the companies closest to it by revenue in the Infrastructure industry (Project Management). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Kompella Tech Private Limited₹1.54 Cr (FY 2025)••••••••194.0%••••Delhi, India
Skillar Enterprise India Private Limited₹1.52 Cr (FY 2021)••••••••13.0%••••Delhi, India
CCRT Laboratories Private Limited₹1.52 Cr (FY 2025)••••••••29.0%••••Thane, Maharashtra, India
Wellingtone Project Management (India) Private Limited₹1.5 Cr (FY 2024)••••••••275.0%••••Ahmedabad, Gujarat, India
Plannerfy Private Limited₹1.49 Cr (FY 2025)••••••••24.0%••••Viman Nagar, Pune, Maharashtra, India
Sanda Pharmaprojects Private Limited this company₹1.49 Cr (FY 2024)••••••••70.0%••••Thane, Maharashtra, India
Akd Consultant India Private Limited₹1.47 Cr (FY 2024)••••••••738.0%••••Delhi, India
Buildsworth Design Consultants Private Limited₹1.44 Cr (FY 2025)••••••••41.0%••••Kolkata, West Bengal, India
G M Kakde Engineering Consultants Private Limited₹1.43 Cr (FY 2018)••••••••-5.0%••••Mumbai, Maharashtra, India
Tree Engineering Consultants Private Limited₹1.42 Cr (FY 2025)••••••••-11.0%••••Kanayannur, Kerala, India
Meera Projects Private Limited₹1.41 Cr (FY 2025)••••••••1429.0%••••Ahmedabad, Gujarat, India

Peers are the five companies nearest above and the five nearest below Sanda Pharmaprojects by revenue in the Infrastructure industry (Project Management), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Sanda Pharmaprojects Private Limited

Sanda Pharmaprojects Private Limited is audited by V R JOBANPUTRA AND ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
V R JOBANPUTRA AND ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Sanda Pharmaprojects Private Limited

Sanda Pharmaprojects has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sandeep Vilasrao PatilDirector06 Aug 20197 Years 2 MonthsCurrent
Sheetal Virendrasingh GiraseDirector06 Aug 20197 Years 2 MonthsCurrent

Ownership and Shareholding of Sanda Pharmaprojects Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Sanda Pharmaprojects Private Limited

Open charges
₹37.21 Lakh
Satisfied charges
None
Breakdown by lending institutions
Axis Bank Limited₹0.22 Cr
Hdfc Bank Limited₹0.16 Cr
Latest charge details
DateLenderAmountStatus
26 Aug 2022Hdfc Bank Limited₹15.64 LakhOpen
15 Aug 2022Axis Bank Limited₹21.57 LakhOpen

Total charge records: 2 View all charges

Employees and EPFO Compliance at Sanda Pharmaprojects Private Limited

Employment history and EPFO contributions of people linked to Sanda Pharmaprojects.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Sanda Pharmaprojects Private Limited

Sanda Pharmaprojects Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Sandeep Vilasrao Patil was appointed as Director on 06 Aug 2019.

AGM
Sanda Pharmaprojects Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sanda Pharmaprojects Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.64 Lakh with Charge ID 100675627 was registered on 26 Aug 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 21.57 Lakh with Charge ID 100644252 was registered on 15 Aug 2022.
Appointed
Sandeep Vilasrao Patil was appointed as Director.
Appointed
Sheetal Virendrasingh Girase was appointed as Director.
Incorporation
06 Aug 2019
Sanda Pharmaprojects Private Limited was registered on 06 Aug 2019 with Roc Mumbai & aged 7 years 2 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Sanda Pharmaprojects Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sanda Pharmaprojects Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Sanda Pharmaprojects Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Sanda Pharmaprojects Private Limited

Sanda Pharmaprojects has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27ABCCS4583N1ZPMaharashtraActive26 Nov 2019
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sanda Pharmaprojects Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanda Pharmaprojects Private Limited

Sanda Pharmaprojects is an active private limited company based in Thane, Maharashtra, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 06 August 2019 (7+ years old) and is registered under CIN U24239MH2019PTC328946.

Sanda Pharmaprojects reported revenue of ₹1.49 Cr for FY 2024 (up 70% YoY).

Sanda Pharmaprojects has 2 current directors:

Sanda Pharmaprojects reported a net profit of ₹13.29 Lakh (net margin 8.9%) and EBITDA of ₹24.72 Lakh (EBITDA margin 16.6%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Sanda Pharmaprojects is 77% over three years. In the latest year (FY 2024) revenue rose 70%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Sanda Pharmaprojects is 27ABCCS4583N1ZP, registered in Maharashtra.

The CIN (Corporate Identification Number) of Sanda Pharmaprojects is U24239MH2019PTC328946. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sanda Pharmaprojects was incorporated on 06 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Sanda Pharmaprojects by revenue are Kompella Tech Private Limited, Skillar Enterprise India Private Limited, CCRT Laboratories Private Limited, Wellingtone Project Management (India) Private Limited, Plannerfy Private Limited and 5 more, all in the Infrastructure industry (Project Management).

Sandeep Vilasrao Patil was appointed as Director on 06 Aug 2019. Sheetal Virendrasingh Girase was appointed as Director on 06 Aug 2019.

Sanda Pharmaprojects can be reached through the website snapharmaprojects.com. Its registered office is in Thane, Maharashtra, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available